Key Events This Week
07 Sep: New 52-week high at Rs.110.76
08 Sep: Upper circuit hit, closing at Rs.114.13
09 Sep: New 52-week high and upper circuit at Rs.119.83
10 Sep: New 52-week high and upper circuit at Rs.125.82
11 Sep: New 52-week high at Rs.130, followed by lower circuit hit at Rs.118.56
07 September 2026: New 52-Week High at Rs.110.76 Amid Market Weakness
Valiant Laboratories Ltd began the week on a strong note, hitting a new 52-week high of Rs.110.76. The stock closed at Rs.108.56, up 1.20% on the day, while the Sensex declined by 0.46%. This marked the fourth consecutive day of gains for the stock, which had delivered an 18.68% return over that period. Despite intraday volatility, the stock maintained a bullish technical stance, trading above all key moving averages. The Mojo Grade upgrade to Hold on 19 August 2026 provided additional confidence amid a bearish broader market.
08 September 2026: Upper Circuit Triggered at Rs.114.13 on Strong Buying Momentum
On 8 September, Valiant Laboratories surged to its upper circuit limit, closing at Rs.114.13 with a 4.99% gain. The stock opened with a gap-up of 2% and outperformed its sector by 4.89%, while the Sensex declined by 0.21%. The rally was supported by a 150.57% increase in delivery volumes, indicating genuine investor participation. The stock’s micro-cap status did not deter strong demand, and technical indicators remained bullish with the stock trading above all major moving averages. The upper circuit hit triggered a regulatory freeze, reflecting unfilled demand and sustained investor enthusiasm.
Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!
- - New Top 1% entry
- - Market attention building
- - Early positioning opportunity
09 September 2026: Sixth Consecutive Gain and Upper Circuit at Rs.119.83
Valiant Laboratories continued its impressive rally, hitting a new 52-week high of Rs.119.67 and closing at Rs.119.83 after hitting the upper circuit limit with a 4.99% gain. This marked six consecutive days of gains, delivering a cumulative return of 30.88%. The stock outperformed its sector and the Sensex, which declined by 0.62% and 0.8% respectively. Technical momentum remained strong with the stock trading above all key moving averages. Despite some mixed signals from momentum indicators like RSI and KST, the overall trend was bullish. Delivery volumes surged, reflecting growing investor conviction.
10 September 2026: New 52-Week High and Upper Circuit at Rs.125.82
On 10 September, Valiant Laboratories hit a new 52-week high of Rs.125.65 and closed at Rs.125.82 after hitting the upper circuit limit with a 5.0% gain. This extended the winning streak to seven days, with a total return of 37.42%. The stock outperformed the Pharmaceuticals & Biotechnology sector, which declined by 0.13%, and the Sensex, which was nearly flat. Trading volumes increased to over 1 lakh shares, supporting the rally despite the micro-cap classification. Technical indicators remained bullish, with the stock trading comfortably above all major moving averages. The Mojo Grade Hold rating and a Mojo Score of 61.0 reinforced the positive sentiment.
Is Valiant Laboratories Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
11 September 2026: New 52-Week High at Rs.130 Followed by Lower Circuit Hit
Valiant Laboratories reached a fresh 52-week high of Rs.130 intraday on 11 September, closing with a 3.42% gain at Rs.127.48. This marked eight consecutive days of gains and a cumulative return of 39.3%. However, the stock also experienced a sharp reversal, hitting the lower circuit limit at Rs.118.56 by the close, a 5.0% decline from the previous day’s close. The intraday volatility of 8.25% reflected active trading and investor uncertainty. Despite the setback, the stock remained above all key moving averages, maintaining a bullish longer-term technical stance. The Mojo Score of 61.0 and Hold rating continue to reflect moderate confidence amid the micro-cap’s inherent volatility.
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-07 | Rs.108.56 | +1.20% | 36,218.97 | -0.46% |
| 2026-09-08 | Rs.113.98 | +4.99% | 36,144.32 | -0.21% |
| 2026-09-09 | Rs.119.67 | +4.99% | 35,921.77 | -0.62% |
| 2026-09-10 | Rs.124.83 | +4.31% | 35,912.77 | -0.03% |
| 2026-09-11 | Rs.127.48 | +2.12% | 35,773.24 | -0.39% |
Key Takeaways
Strong Outperformance: Valiant Laboratories Ltd outpaced the Sensex by a wide margin, gaining 18.84% over the week while the Sensex declined 1.68%, highlighting the stock’s resilience and investor appeal amid a weak broader market.
Consistent Momentum: The stock recorded eight consecutive days of gains, hitting multiple new 52-week highs and triggering upper circuit limits on three separate days, signalling robust buying interest and technical strength.
Technical Strength with Caution: Trading above all major moving averages and supported by bullish MACD and Bollinger Bands, the stock’s technical setup is positive. However, bearish RSI and mixed momentum indicators suggest potential short-term overbought conditions and the need for caution.
Mojo Grade Upgrade: The upgrade from Sell to Hold with a Mojo Score of 61.0 reflects improved fundamentals and market sentiment, aligning with the stock’s price appreciation and technical momentum.
Micro-Cap Volatility: Despite strong gains, the stock’s micro-cap status entails higher volatility, as evidenced by the lower circuit hit on 11 September following the new high, underscoring the importance of monitoring liquidity and price swings.
Volume and Delivery Trends: Increasing delivery volumes and moderate traded volumes support the rally’s sustainability, indicating genuine investor participation rather than speculative trading.
Sectoral Context: The Pharmaceuticals & Biotechnology sector showed mixed performance, with Valiant Laboratories standing out as a notable outperformer, suggesting company-specific catalysts or favourable positioning within the sector.
Market Environment: The broader market remained subdued, with the Sensex trading below key moving averages and on a losing streak, highlighting the stock’s relative strength in a challenging environment.
Conclusion
Valiant Laboratories Ltd’s impressive 18.84% weekly gain, driven by a series of new 52-week highs and multiple upper circuit hits, underscores its strong momentum and relative strength amid a bearish broader market. The stock’s technical indicators and upgraded Mojo Grade to Hold reflect improved fundamentals and investor confidence. However, the micro-cap nature and recent lower circuit hit highlight the inherent volatility and caution warranted in the near term. Investors should continue to monitor volume trends, technical signals, and sector developments to assess the sustainability of this rally. Overall, Valiant Laboratories remains a noteworthy performer in the Pharmaceuticals & Biotechnology sector, demonstrating resilience and robust price action during a challenging market phase.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
